[1] |
WU Wen, ZHANG Ruoxin, WENG Junyong, MA Yanlei, CAI Guoxiang, LI Xinxiang, YANG Yongzhi.
Exploring the prognostic value of positive lymph node ratio in stage Ⅲ colorectal cancer patients and establishing a predictive model
[J]. China Oncology, 2024, 34(9): 873-880.
|
[2] |
XIAO Feng, XU Tonglin, ZHU Lin, XIAO Jingwen, WU Tianqi, GU Chunyan.
Significance of infiltration of M1 tumor-associated macrophages in hepatocellular carcinoma
[J]. China Oncology, 2024, 34(8): 726-733.
|
[3] |
ZHANG Ruoxin, YE Zilan, WENG Junyong, LI Xinxiang.
Correlation study between advanced age and inferior prognosis in stage Ⅱ colorectal cancer patients
[J]. China Oncology, 2024, 34(5): 485-492.
|
[4] |
LIN Yicong, WANG Yue, XUE Qianqian, ZHENG Qiang, JIN Yan, HUANG Ziling, LI Yuan.
Clinical pathological characteristics and immune microenvironment significance of EGFR T790M mutation in non-small cell lung cancer patients and its prognostic implications
[J]. China Oncology, 2024, 34(4): 368-379.
|
[5] |
LI Jun, LU Tingwei, FANG Xuqian.
Impact of MSI-H/dMMR on clinicopathological characteristics and prognosis of patients with BRAF V600E-mutated resectable colorectal cancer
[J]. China Oncology, 2024, 34(11): 1061-1066.
|
[6] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Receptor discordance between primary breast cancer and liver metastases
[J]. China Oncology, 2023, 33(9): 834-843.
|
[7] |
WU Han, YANG Zhangru, FENG Wen, ZENG Wanqin, GUO Jindong, LI Hongxuan, WANG Changlu, WANG Jiaming, LÜ Changxing, ZHANG Qin, YU Wen, CAI Xuwei, FU Xiaolong.
The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer
[J]. China Oncology, 2023, 33(9): 844-856.
|
[8] |
CHEN Jinjuan, WANG Xingran, LI Wenzhi, CHENG Yu, SUN Yihua, TAO Xiang, MA Fenghua, SUN Li, ZHAO Hongbo, LU Xin.
Conservative surgery in stage I placental site trophoblastic tumor: a report of 10 cases and literature review
[J]. China Oncology, 2023, 33(9): 857-865.
|
[9] |
SUN Yang, WANG Lian, ZHAO Meng, ZHANG Xiaofeng, GENG Zhijun, WANG Yueyue, SONG Xue, ZUO Lugen, LI Jing, HU Jianguo.
The prognostic value of high expression of FKBP1A in gastric cancer and the regulatory effect of targeted PI3K/AKT on glucose metabolism
[J]. China Oncology, 2023, 33(8): 726-739.
|
[10] |
JIANG Lin, LIU Qiying, JIA Liqing, ZHANG Jing, CHANG Heng, XUE Tian, REN Min, BAI Qianming, ZHU Xiaoli, ZHOU Xiaoyan.
Retrospective study on MGMT methylation status and its clinical significance in gliomas
[J]. China Oncology, 2023, 33(8): 740-750.
|
[11] |
ZHANG Lingling, WANG Xiangyi, WEI Xing, LIN Li, TANG Chuanhao, LIANG Jun.
A study on prevention and treatment of chemotherapy induced nausea and vomiting in non-small cell lung cancer patients with low-frequency electrical stimulator for antiemesis
[J]. China Oncology, 2023, 33(8): 776-781.
|
[12] |
WANG Ruoxi, JI Peng, GONG Yue, CHEN Sheng.
Response rate and clinical outcome of HER2-low breast cancer after neoadjuvant therapy: a single-center retrospective study
[J]. China Oncology, 2023, 33(7): 686-692.
|
[13] |
ZUO Xueliang, CHEN Zhiqiang, DONG Runyu, WANG Zhixiong, CAI Juan.
The value of combined detection of LDHA and PD-L1 in predicting the efficacy and prognosis of advanced gastric cancer patients treated with PD-1 inhibitor
[J]. China Oncology, 2023, 33(5): 460-468.
|
[14] |
SU Chunxia, ZHOU Caicun.
Important clinical research progress in lung cancer in 2022
[J]. China Oncology, 2023, 33(3): 218-227.
|
[15] |
CHEN Yuguang, SUN Xiao, BI Zhao, QIU Pengfei, DUAN Baowei, FAN Qingda, WANG Yongsheng.
Internal mammary sentinel lymph node biopsy for breast cancer: a long-term follow-up research for assessment of prognosis and guiding individualized internal mammary lymph node irradiation
[J]. China Oncology, 2023, 33(2): 142-151.
|